Skip to main content

Table 4 Effect of supplementation of a hydrogenated trans fat and a corn-oil based low trans structured fat on plasma, hepatic and fecal lipid levels in apo E-/- mice.

From: Differential effect of corn oil-based low trans structured fat on the plasma and hepatic lipid profile in an atherogenic mouse model: comparison to hydrogenated trans fat

  CS LC
Plasma lipids   
   Free fatty acid (mmol/L) 1.14 ± 0.03 1.11 ± 0.04
   Triglyceride (mmol/L) 1.46 ± 0.09 2.09 ± 0.08***
   Total-C (mmol/L) 16.45 ± 0.81 18.75 ± 0.37*
   HDL-C (mmol/L) 0.11 ± 0.02 0.81 ± 0.06***
   HDL-C/Total-C (%) 0.60 ± 0.06 4.06 ± 0.39***
   Atherogenic indexa 174.95 ± 18.05 23.39 ± 1.99***
   Apo A-I (mg/dL) 4.46 ± 0.57 7.47 ± 0.25***
   Apo B (mg/dL) 21.00 ±0.54 17.19 ± 0.60***
Hepatic lipids   
   Cholesterol (mmol/g liver) 7.88 ± 0.03 5.83 ± 0.19***
   Triglyceride (mmol/g liver) 7.21 ± 0.34 5.27 ± 0.18**
Fecal lipids   
   Cholesterol (μmol/g) 4.60 ± 0.28 6.44 ± 0.37**
   Triglyceride (μmol/g) 2.22 ± 0.54 4.44 ± 0.85*
  1. Data are mean ± S.E. (n = 10). Values are significantly different from the CS group according to Student's t test: *P < .05, **P < .01, ***P < .001. C:cholesterol.
  2. a Atherogenic index: (Total-C-HDL-C)/HDL-C
  3. CS, commercial shortening; LC, low trans structured fat from corn oil